{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T21:13:21Z","timestamp":1784841201099,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T00:00:00Z","timestamp":1507507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T00:00:00Z","timestamp":1507507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1038\/bmt.2017.230","type":"journal-article","created":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T13:41:17Z","timestamp":1507556477000},"page":"228-230","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high risk"],"prefix":"10.1038","volume":"53","author":[{"given":"A","family":"Re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Gini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Rupolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Levis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bandera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Liberati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Tozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Casari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Skert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Bocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Spina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Allione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Verga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Michieli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Almici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P F","family":"Leali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Tirelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of GICAT and FIL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,9]]},"reference":[{"key":"BFbmt2017230_CR1","doi-asserted-by":"publisher","first-page":"8477","DOI":"10.1200\/JCO.2005.02.9355","volume":"23","author":"ST Lim","year":"2005","unstructured":"Lim ST, Karim R, Tulpule A, Nathwani BN, Levine AM . Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy. J Clin Oncol 2005; 23: 8477\u20138482.","journal-title":"J Clin Oncol"},{"key":"BFbmt2017230_CR2","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11<2391::AID-CNCR29>3.0.CO;2-0","volume":"86","author":"G Rossi","year":"1999","unstructured":"Rossi G, Donisi A, Casari S, Re A, Cadeo G, Carosi G . The International Prognostic Index can be used as a guide to treatment decisions regarding patients with immunodeficiency virus-related systemic non-Hodgkin lymphoma. Cancer 1999; 86: 2391\u20132397.","journal-title":"Cancer"},{"key":"BFbmt2017230_CR3","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1182\/blood-2005-04-1437","volume":"106","author":"LD Kaplan","year":"2005","unstructured":"Kaplan LD, Lee JY, Ambinder RF, Sparano JA, Cesarman E, Chadburn A et al. Rituximab does not improve clinical outcome, in a randomized phase III trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin\u2019s lymphoma. AIDS Malignancies Consortium Trial 010. Blood 2005; 106: 1538\u20131543.","journal-title":"Blood"},{"key":"BFbmt2017230_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1365-2141.2007.06943.x","volume":"140","author":"JM Ribera","year":"2007","unstructured":"Ribera JM, Oriol A, Morgades M, Gonz\u00e1lez-Barca E, Miralles P, L\u00f3pez-Guillermo A et al. Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial. Br J Haematol 2007; 140: 411\u2013419.","journal-title":"Br J Haematol"},{"key":"BFbmt2017230_CR5","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/annonc\/mdv036","volume":"26","author":"SK Barta","year":"2015","unstructured":"Barta SK, Samuel MS, Xue X, Wang D, Lee JY, Mounier N et al. Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma. Ann Oncol 2015; 26: 958\u2013966.","journal-title":"Ann Oncol"},{"key":"BFbmt2017230_CR6","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1200\/JCO.2008.18.2683","volume":"27","author":"P Balsalobre","year":"2009","unstructured":"Balsalobre P, D\u00edez-Mart\u00edn JL, Re A, Michieli M, Ribera JM, Canals C et al. Autologous stem-cell transplantation in patients with HIV-related lymphoma. J Clin Oncol 2009; 27: 2192\u20132198.","journal-title":"J Clin Oncol"},{"key":"BFbmt2017230_CR7","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1182\/blood-2009-02-202762","volume":"114","author":"A Re","year":"2009","unstructured":"Re A, Michieli M, Casari S, Allione B, Cattaneo C, Rupolo M et al. High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors. Blood 2009; 114: 1306\u20131313.","journal-title":"Blood"},{"key":"BFbmt2017230_CR8","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1182\/blood.V98.13.3857","volume":"98","author":"A Krishnan","year":"2001","unstructured":"Krishnan A, Molina A, Zaia J, Nademanee A, Kogut N, Rosenthal J et al. Autologous stem cell transplantation for HIV-associated lymphoma. Blood 2001; 98: 3857\u20133859.","journal-title":"Blood"},{"key":"BFbmt2017230_CR9","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.1182\/blood-2008-12-195388","volume":"113","author":"JL D\u00edez-Mart\u00edn","year":"2009","unstructured":"D\u00edez-Mart\u00edn JL, Balsalobre P, Re A, Michieli M, Ribera JM, Canals C et al. Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation. Blood 2009; 113: 6011\u20136014.","journal-title":"Blood"},{"key":"BFbmt2017230_CR10","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1182\/blood-2015-08-664706","volume":"128","author":"JC Alvarnas","year":"2016","unstructured":"Alvarnas JC, Le Rademacher J, Wang Y, Little RF, Akpek G, Ayala E et al. Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the (BMT CTN) 0803\/(AMC) 071 Trial. Blood 2016; 128: 1050\u20131058.","journal-title":"Blood"},{"key":"BFbmt2017230_CR11","doi-asserted-by":"publisher","first-page":"37995","DOI":"10.1038\/srep37995","volume":"6","author":"D Bertoli","year":"2016","unstructured":"Bertoli D, Re A, Chiarini M, Sottini A, Serana F, Giustini V et al. Number and function of B and T cells in HIV+ and HIV- patients with lymphoma after chemotherapy and autologous stem cell transplantation. Sci Rep 2016; 6: 37995.","journal-title":"Sci Rep"},{"key":"BFbmt2017230_CR12","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1182\/blood-2008-06-162289","volume":"112","author":"JE Amengual","year":"2008","unstructured":"Amengual JE, Zhang X, Ibrahim S, Gardner LB . Regression of HIV-related diffuse large B-cell lymphoma in response to antiviral therapy alone. Blood 2008; 112: 4359\u20134360.","journal-title":"Blood"},{"key":"BFbmt2017230_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1470-2045(08)70334-6","volume":"10","author":"WA Chow","year":"2009","unstructured":"Chow WA, Jiang C, Guan M . Anti-HIV drugs for cancer therapeutics: back to the future? Lancet Oncol 2009; 10: 61\u201371.","journal-title":"Lancet Oncol"},{"key":"BFbmt2017230_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2174\/157340608783331443","volume":"4","author":"SA Rizza","year":"2008","unstructured":"Rizza SA, Badley AD . HIV protease inhibitors impact on apoptosis. Med Chem 2008; 4: 75\u201379.","journal-title":"Med Chem"},{"key":"BFbmt2017230_CR15","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1200\/JCO.2005.05.4684","volume":"25","author":"F Bou\u00e8","year":"2006","unstructured":"Bou\u00e8 F, Gabarre J, Gisselbrecht C, Reynes J, Cheret A, Bonnet F et al. Phase II trial of CHOP plus rituximab in patients with HIV-associated non \u2013Hodgkin\u2019s lymphoma. J Clin Oncol 2006; 25: 4123\u20134128.","journal-title":"J Clin Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2017230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2017230","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/bmt.2017.230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2017230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:04:32Z","timestamp":1648062272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2017230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,9]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["BFbmt2017230"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2017.230","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,9]]},"assertion":[{"value":"9 October 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}